Biomarkers for Radiation Oncology

The discovery and validation of new biomarkers will help transform the delivery of radiation therapy and improve outcomes for patients with cancer. Through this RFP, the ROI is seeking innovative ideas to leverage biomarkers for radiation oncology to enhance patient selection, to develop personalized treatment regimes, and to quantify outcomes and manage toxicity. The ROI focuses on research to heighten the critical role of radiation therapy in the treatment of cancer.

Funding: $150,000 total 

Duration: 2 years 

Research Authority due date: 9.11.20

LOI (required) due date: 16.11.20

Full proposal due date: 5.2.21